Neogen Chemicals Limited (BOM:542665)
India · Delayed Price · Currency is INR 1,783.80
+9.65 (0.54%)
At close: May 27, 2026
Neogen Chemicals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 287.5 | 348.3 | 356.5 | 499.7 | 446.3 |
Depreciation & Amortization | 275.2 | 275.4 | 225.9 | 159 | 116.2 |
Other Amortization | - | 2.5 | 2.8 | 3 | 0.7 |
Loss (Gain) From Sale of Assets | 0.2 | - | - | - | -1.1 |
Loss (Gain) From Sale of Investments | -9.6 | - | - | - | - |
Provision & Write-off of Bad Debts | 37.2 | 17.9 | - | - | - |
Other Operating Activities | 664.2 | 668.3 | 410.9 | 393.8 | 152.8 |
Change in Accounts Receivable | -1,831 | 786.6 | -1,043 | -669.8 | -311.6 |
Change in Inventory | -2,592 | -1,202 | -894.7 | -983.8 | -805.6 |
Change in Accounts Payable | 1,771 | 1,132 | -108.9 | 532 | 398.6 |
Change in Other Net Operating Assets | -917.4 | -69.9 | 758.8 | -237.4 | 17.8 |
Operating Cash Flow | -2,315 | 1,960 | -291.5 | -303.5 | 14.1 |
Operating Cash Flow Growth | - | - | - | - | -98.31% |
Capital Expenditures | -5,557 | -3,177 | -3,028 | -1,025 | -1,703 |
Sale of Property, Plant & Equipment | - | 4.8 | - | - | 1.1 |
Cash Acquisitions | - | - | 35.2 | - | - |
Sale (Purchase) of Intangibles | -0.1 | -0.4 | -0.1 | -12.5 | 1.7 |
Investment in Securities | 19.9 | -4.5 | - | 47 | -807.6 |
Other Investing Activities | 1,435 | 10.9 | 73.1 | 45.8 | 1,049 |
Investing Cash Flow | -4,103 | -3,166 | -2,156 | -944.6 | -1,458 |
Long-Term Debt Issued | 8,349 | 2,443 | 747.1 | 2,261 | 388.8 |
Total Debt Issued | 8,349 | 2,443 | 747.1 | 2,261 | 388.8 |
Long-Term Debt Repaid | -805.6 | -781.2 | -352.9 | -899.9 | -430.4 |
Net Debt Issued (Repaid) | 7,544 | 1,662 | 394.2 | 1,361 | -41.6 |
Issuance of Common Stock | - | - | 2,467 | - | 2,250 |
Repurchase of Common Stock | -7.9 | - | - | - | - |
Common Dividends Paid | -26.4 | -52.8 | -74.8 | -68.6 | -52.5 |
Dividends Paid | -26.4 | -52.8 | -74.8 | -68.6 | -52.5 |
Other Financing Activities | -1,092 | -478.4 | -420.6 | -289.4 | -271.6 |
Financing Cash Flow | 6,417 | 1,131 | 2,365 | 1,003 | 1,884 |
Miscellaneous Cash Flow Adjustments | 0.1 | - | - | - | - |
Net Cash Flow | -0.2 | -75.4 | -82 | -245.2 | 440.1 |
Free Cash Flow | -7,872 | -1,217 | -3,319 | -1,328 | -1,689 |
Free Cash Flow Margin | -91.33% | -15.65% | -48.06% | -19.36% | -34.66% |
Free Cash Flow Per Share | -298.45 | -46.13 | -129.96 | -53.27 | -67.71 |
Cash Interest Paid | 1,092 | 378.6 | 377.8 | 237 | 178 |
Cash Income Tax Paid | 196.7 | 123 | 97.5 | 115.2 | 98 |
Levered Free Cash Flow | -5,691 | -3,946 | -3,797 | -1,615 | -2,230 |
Unlevered Free Cash Flow | -5,222 | -3,709 | -3,561 | -1,467 | -2,119 |
Change in Working Capital | -3,570 | 647.4 | -1,288 | -1,359 | -700.8 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.